| P2093 | author name string | Man-Hui Pai | |
| | Sung-Ling Yeh | |
| | Ya-Mei Hu | |
| | Yuan-Chin Hsiung | |
| P2860 | cites work | Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection | Q24564396 |
| | Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 |
| | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 |
| | Molecular mechanisms of T cell co-stimulation and co-inhibition | Q26864888 |
| | High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 |
| | Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 |
| | The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation | Q34242691 |
| | Impact of sepsis on CD4 T cell immunity | Q34341378 |
| | PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis | Q34605998 |
| | PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation | Q35311785 |
| | Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. | Q35559497 |
| | PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction | Q35561405 |
| | Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 |
| | The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection | Q36737159 |
| | Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial. | Q36927395 |
| | Glutamine: role in critical illness and ongoing clinical trials | Q37095130 |
| | Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis | Q37279796 |
| | Immunodesign of experimental sepsis by cecal ligation and puncture | Q37368111 |
| | Effects of dietary glutamine on the homeostasis of CD4+ T cells in mice with dextran sulfate sodium-induced acute colitis | Q37458560 |
| | Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report | Q37698325 |
| | T cells are potent early mediators of the host response to sepsis. | Q37729791 |
| | Sepsis and acute kidney injury | Q37874863 |
| | Parenteral glutamine supplementation in critical illness: a systematic review | Q38205494 |
| | Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. | Q38483410 |
| | Sepsis and septic shock--a review of laboratory models and a proposal | Q40290200 |
| | Monocyte deactivation--rationale for a new therapeutic strategy in sepsis | Q41219022 |
| | A randomized trial of glutamine and antioxidants in critically ill patients | Q42266312 |
| | Effect of resveratrol on tubular damage and interstitial fibrosis in kidneys of rats exposed to cigarette smoke | Q43262241 |
| | Plasma glutamine depletion and patient outcome in acute ICU admissions | Q43561049 |
| | Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels | Q44092035 |
| | Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat. | Q44287725 |
| | Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: a multicenter analysis*. | Q46327122 |
| | Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression | Q46533733 |
| | Possible biomarkers of early mortality in peritonitis-induced sepsis rats | Q46745583 |
| | Glutamine administration modulates lung γδ T lymphocyte expression in mice with polymicrobial sepsis | Q48369520 |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 148607117695245 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Journal of Parenteral and Enteral Nutrition | Q6295717 |
| P1476 | title | Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis | |